16-29830659-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_005115.5(MVP):c.110G>A(p.Arg37Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000236 in 1,613,290 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000025 ( 1 hom. )
Consequence
MVP
NM_005115.5 missense
NM_005115.5 missense
Scores
6
7
6
Clinical Significance
Conservation
PhyloP100: 6.68
Genes affected
MVP (HGNC:7531): (major vault protein) This gene encodes the major component of the vault complex. Vaults are multi-subunit ribonucleoprotein structures that may be involved in nucleo-cytoplasmic transport. The encoded protein may play a role in multiple cellular processes by regulating the MAP kinase, JAK/STAT and phosphoinositide 3-kinase/Akt signaling pathways. The encoded protein also plays a role in multidrug resistance, and expression of this gene may be a prognostic marker for several types of cancer. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MVP | NM_005115.5 | c.110G>A | p.Arg37Gln | missense_variant | 2/15 | ENST00000357402.10 | NP_005106.2 | |
MVP | NM_017458.3 | c.110G>A | p.Arg37Gln | missense_variant | 2/15 | NP_059447.2 | ||
MVP | NM_001293204.1 | c.110G>A | p.Arg37Gln | missense_variant | 1/14 | NP_001280133.1 | ||
MVP | NM_001293205.1 | c.110G>A | p.Arg37Gln | missense_variant | 1/13 | NP_001280134.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MVP | ENST00000357402.10 | c.110G>A | p.Arg37Gln | missense_variant | 2/15 | 1 | NM_005115.5 | ENSP00000349977.5 | ||
ENSG00000281348 | ENST00000562285.1 | n.*334G>A | downstream_gene_variant | 2 | ENSP00000457363.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151488Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
2
AN:
151488
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250878Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135630
GnomAD3 exomes
AF:
AC:
2
AN:
250878
Hom.:
AF XY:
AC XY:
1
AN XY:
135630
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461802Hom.: 1 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 727218
GnomAD4 exome
AF:
AC:
36
AN:
1461802
Hom.:
Cov.:
31
AF XY:
AC XY:
21
AN XY:
727218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151488Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 73982
GnomAD4 genome
AF:
AC:
2
AN:
151488
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
73982
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2023 | The c.110G>A (p.R37Q) alteration is located in exon 2 (coding exon 1) of the MVP gene. This alteration results from a G to A substitution at nucleotide position 110, causing the arginine (R) at amino acid position 37 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;D;D;T;.;.;.;T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;.;D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;M;M;.;.;.;.;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D;D;D;D;D;D
REVEL
Uncertain
Sift
Uncertain
D;T;T;D;D;D;D;T
Sift4G
Uncertain
T;T;T;D;D;D;T;T
Polyphen
1.0
.;D;D;.;.;.;.;.
Vest4
0.58, 0.58
MutPred
Loss of MoRF binding (P = 0.0558);Loss of MoRF binding (P = 0.0558);Loss of MoRF binding (P = 0.0558);Loss of MoRF binding (P = 0.0558);Loss of MoRF binding (P = 0.0558);Loss of MoRF binding (P = 0.0558);Loss of MoRF binding (P = 0.0558);Loss of MoRF binding (P = 0.0558);
MVP
MPC
1.2
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at